NASDAQ:ICEL

(ICEL) (ICEL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
264,387 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ICEL stock logo

About (ICEL) Stock (NASDAQ:ICEL)

Cellular Dynamics International, Inc. develops and produces functioning human cells in industrial quantities. The Company's products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). It markets its products for use in life science in vitro research and development, as well as applied product testing, stem cell banking and in vivo cellular therapeutics. It is also in the process of developing human cells as cellular therapeutics. The market for in vitro drug discovery, toxicity testing and applied testing, including chemical safety, has employed models, such as primary cells, transformed (immortalized) cells and live animals that act as surrogates for functioning human cells. Its iCell and MyCell products consist of iCell Cardiomyocytes, iCell Neurons, iCell DopaNeurons, iCell Endothelial Cells, iCell Hepatocytes, MyCell and Media and reprogramming kit.

ICEL Stock News Headlines

Iceland volcano erupts on Reykjanes peninsula
See More Headlines
Receive ICEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ICEL) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2015
Today
5/14/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ICEL
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

ICEL Stock Analysis - Frequently Asked Questions

How were (ICEL)'s earnings last quarter?

(ICEL) (NASDAQ:ICEL) posted its earnings results on Thursday, March, 5th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.08. The company earned $6.60 million during the quarter, compared to analysts' expectations of $5 million.

What other stocks do shareholders of (ICEL) own?
This page (NASDAQ:ICEL) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners